41 – 50 of 73
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD
- Contribution to journal › Scientific review
-
Mark
Cysteinyl–leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics
- Contribution to journal › Letter
-
Mark
Single-nucleotide polymorphisms in the sulfatase-modifying factor 1 gene are associated with lung function and COPD
- Contribution to journal › Article
- 2021
-
Mark
A new protocol for exercise testing in COPD; improved prediction algorithm for WMAX and validation of the endurance test in a placebo-controlled double bronchodilator study
- Contribution to journal › Article
-
Mark
ERS/EAACI statement on adherence to international adult asthma guidelines
- Contribution to journal › Scientific review
-
Mark
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening : a post hoc analysis of the EMAX trial
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD : A Prespecified Analysis of The EMAX Trial
- Contribution to journal › Article
-
Mark
Impaired differentiation of chronic obstructive pulmonary disease bronchial epithelial cells grown on bronchial scaffolds
- Contribution to journal › Article
-
Mark
Wtreatment of copd with long-acting bronchodilators : Association between early and longer-term clinically important improvement
- Contribution to journal › Article
-
Mark
Non-exacerbating patients with COPD from a UK perspective using the galaxy model
- Contribution to journal › Article
